Tradestie Institutional Equity Comparison Engine

NVS vs GNPX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NVS Overall Edge

NVS Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novartis AG (NVS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NVS trades at 15.2x Forward P/E with 34.0% operating margin (+4.7% YoY revenue) versus GNPX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner NVS
NVS 15.2x vs GNPX N/M Fwd P/E
Growth & Margin Winner NVS
Op Margin 34.0% vs 0.0% ยท YoY +4.7% vs +0.0%
Momentum & Technical Winner NVS
1Y +18.2% vs -56.6% ยท 52W Pos 58% vs 11%
Options & Structure Winner NVS
UNCLASSIFIED (6th %ile IV) vs UNCLASSIFIED (N/A IV)
NVS NYSE
Novartis AG
Pharmaceutical Preparations
$150.47
-0.5% 1D
Market Cap $285.6B
1M Return -3.71%
1Y Return +18.19%
Forward P/E 15.2x
Unified AI Score
37.0 / 100 SELL
Tech 20.0 Fund 34.0 Flow 50.0 Mom 36.0
GNPX NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap $2.2M
1M Return -26.77%
1Y Return -56.59%
Forward P/E N/M
Unified AI Score
42.2 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NVS +18.19% GNPX -56.59% Spread: +74.78 pp (NVS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NVS TTM Op. Margin: 34.0% GNPX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVS vs GNPX. Trailing 12-month operating profitability (NVS 34.0% vs GNPX 0.0%) and valuation multiples (NVS 15.2x vs GNPX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NVS (9) vs GNPX (1)
Institutional Metric NVS GNPX Criterion Row Winner
Market Capitalization Scale $285.6B $2.2M Larger Scale NVS
Trailing P/E Ratio Valuation 28.9x N/M Lower Multiple NVS
Forward P/E Ratio Valuation 15.2x N/M Lower Multiple NVS
Revenue Growth (YoY) Growth +4.7% +0.0% Higher Growth NVS
Operating Margin (TTM) Profitability 34.0% 0.0% Higher Margin NVS
Net Profit Margin Profitability 17.5% 0.0% Higher Margin NVS
Return on Equity (ROE) Capital Efficiency 24.3% -233.7% Higher ROE NVS
52-Week Range Position Momentum 58% ($123โ€“$170) 11% ($0โ€“$10) Stronger Trend NVS
Beta / 30D Volatility Risk Regime 0.32ฮฒ ยท 28% Vol -4.68ฮฒ ยท 96% Vol Lower Realized Risk NVS
Unified Institutional Score Composite Signal 37.0 / 100 (SELL) 42.2 / 100 (HOLD) Higher Composite GNPX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NVS vs GNPX Buy Guide
NVS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live NVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GNPX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GNPX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NVS nor GNPX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.